Recent Updates — ELAB
PMGC Holdings Inc. filed an 8-K to furnish two presentation decks for use in future investor meetings. The first is a general overview of the company's diversified holding strategy, which includes acquisitions in aerospace, defense, packaging, and biotechnology, as well as its sponsorship of NorthStrive Acquisition Corp I, a $100 million SPAC. The second deck details the activities of its subsidiary, NorthStrive Defense Tech LLC, specifically regarding an exclusive license for U.S. Patent No. 12,291,334 covering a buoyancy-assisted drone payload system and current prototype development milestones with Florida State University. PMGC Holdings Inc. is a diversified holding company that acquires cash-flow-positive businesses in manufacturing and technology sectors.
PMGC Holdings Inc. and its subsidiary NorthStrive Biosciences entered into a binding, interest-bearing payment agreement with Longevity Health Holdings to secure royalty payments from the January 2025 sale of Elevai Skincare. The deal converts a 5% net sales royalty into scheduled monthly cash payments of $10,000 starting October 15, 2026, through August 28, 2031. Longevity acknowledged a 2025 royalty obligation of $94,937 accruing interest at the WSJ Prime Rate plus 1.00%. The agreement includes mandatory prepayments of 15% of net cash proceeds from capital raises exceeding $350,000 and annual audit rights. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries.
PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences executed a First Amendment to its Development and License Agreement with Yuva Biosciences, launching a three-phase Expansion Program to advance four AI-discovered compounds toward lead nomination for Cardiac Diseases and Obesity. The amendment updates the program scope, intellectual property framework, field of use definitions, and financial terms. Concurrently, PMGC filed a Certificate of Amendment to its Articles of Incorporation on August 31, 2026, increasing authorized capital stock to 1,500,000,000 shares, comprising 1,000,000,000 common and 500,000,000 preferred shares. This filing was approved by shareholders holding 60.34% of voting power. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries.
On July 2, 2026, PMGC Holdings Inc. entered into a Merger Agreement to merge its wholly owned subsidiary, AGA Precision Systems LLC, into another wholly owned subsidiary, A&B Aerospace, Inc. A&B Aerospace will be the surviving entity, and all membership interests in AGA will be cancelled without consideration. The merger is anticipated to be effective as of July 2, 2026. The company operates in the aerospace and precision manufacturing industry.
PMGC Holdings Inc. through its subsidiary NorthStrive Defense Tech LLC entered into a Standard Exclusive License Agreement with an unnamed licensor to obtain a worldwide, non-transferable, exclusive license for aerospace and defense technologies covered by U.S. Patent No. 12,291,334. The agreement includes a non-refundable license issue fee, annual maintenance fees, and royalties based on Net Sales. PMGC Holdings Inc. operates in the aerospace and defense technology sector.